Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature
2011

Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil

Sample size: 1 publication Evidence: low

Author Information

Author(s): Mannion Melissa, Cron Randy Q

Primary Institution: University of Alabama at Birmingham School of Medicine

Hypothesis

Can mycophenolate mofetil effectively treat pediatric autoimmune pancreatitis associated with elevated IgG4 levels?

Conclusion

The 13-year-old girl with IgG4 related systemic disease was successfully treated with mycophenolate mofetil, allowing for the discontinuation of corticosteroids.

Supporting Evidence

  • The patient had elevated IgG4 levels and was diagnosed with autoimmune pancreatitis.
  • Treatment with mycophenolate mofetil led to significant improvement in symptoms and laboratory findings.
  • After one year of treatment, the patient was symptom-free and off all immunosuppressive therapy.

Takeaway

A girl with a rare type of pancreatitis got better after taking a special medicine instead of steroids, which helped her feel good without side effects.

Methodology

The case of a 13-year-old girl was presented, detailing her symptoms, diagnosis, treatment with mycophenolate mofetil, and follow-up results.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

13-year-old Caucasian female.

Digital Object Identifier (DOI)

10.1186/1546-0096-9-1

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication